Global and United States Prostate Cancer Testing Market Size, Status and Forecast 2020-2026

1 Report Overview

• 1.1 Study Scope
• 1.2 Market Analysis by Type
  • 1.2.1 Global Prostate Cancer Testing Market Size Growth Rate by Type: 2020 VS 2026
  • 1.2.2 PSA Tests
  • 1.2.3 CTC Tests
  • 1.2.4 Immunohistochemistry
  • 1.2.5 PCA3 Tests
  • 1.2.6 Others
• 1.3 Market by Application
  • 1.3.1 Global Prostate Cancer Testing Market Share by Application: 2020 VS 2026
  • 1.3.2 Hospital Associated Labs
  • 1.3.3 Independent Diagnostic Laboratories
  • 1.3.4 Cancer Research Institutes
  • 1.3.5 Others
• 1.4 Study Objectives
• 1.5 Years Considered

2 Global Growth Trends

• 2.1 Global Prostate Cancer Testing Market Perspective (2015-2026)
• 2.2 Global Prostate Cancer Testing Growth Trends by Regions
  • 2.2.1 Prostate Cancer Testing Market Size by Regions: 2015 VS 2020 VS 2026
  • 2.2.2 Prostate Cancer Testing Historic Market Share by Regions (2015-2020)
  • 2.2.3 Prostate Cancer Testing Forecasted Market Size by Regions (2021-2026)
• 2.3 Industry Trends and Growth Strategy
  • 2.3.1 Market Trends
  • 2.3.2 Market Drivers
  • 2.3.3 Market Challenges
  • 2.3.4 Market Restraints

3 Competition Landscape by Key Players

• 3.1 Global Top Prostate Cancer Testing Players by Market Size
  • 3.1.1 Global Top Prostate Cancer Testing Players by Revenue (2015-2020)
  • 3.1.2 Global Prostate Cancer Testing Revenue Market Share by Players (2015-2020)
• 3.2 Global Prostate Cancer Testing Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
• 3.3 Players Covered: Ranking by Prostate Cancer Testing Revenue
• 3.4 Global Prostate Cancer Testing Market Concentration Ratio
  • 3.4.1 Global Prostate Cancer Testing Market Concentration Ratio (CR5 and HHI)
  • 3.4.2 Global Top 10 and Top 5 Companies by Prostate Cancer Testing Revenue in 2019
• 3.5 Key Players Prostate Cancer Testing Area Served
• 3.6 Key Players Prostate Cancer Testing Product Solution and Service
• 3.7 Date of Enter into Prostate Cancer Testing Market
• 3.8 Mergers & Acquisitions, Expansion Plans

4 Prostate Cancer Testing Breakdown Data by Type (2015-2026)

• 4.1 Global Prostate Cancer Testing Historic Market Size by Type (2015-2020)
• 4.2 Global Prostate Cancer Testing Forecasted Market Size by Type (2021-2026)

5 Prostate Cancer Testing Breakdown Data by Application (2015-2026)

• 5.1 Global Prostate Cancer Testing Historic Market Size by Application (2015-2020)
• 5.2 Global Prostate Cancer Testing Forecasted Market Size by Application (2021-2026)

6 North America

• 6.1 North America Prostate Cancer Testing Market Size (2015-2026)
• 6.2 North America Prostate Cancer Testing Market Size by Type (2015-2020)
• 6.3 North America Prostate Cancer Testing Market Size by Application (2015-2020)
• 6.4 North America Prostate Cancer Testing Market Size by Country (2015-2020)
  • 6.4.1 United States
  • 6.4.2 Canada

7 Europe

• 7.1 Europe Prostate Cancer Testing Market Size (2015-2026)
• 7.2 Europe Prostate Cancer Testing Market Size by Type (2015-2020)
• 7.3 Europe Prostate Cancer Testing Market Size by Application (2015-2020)
• 7.4 Europe Prostate Cancer Testing Market Size by Country (2015-2020)
  • 7.4.1 Germany
  • 7.4.2 France
  • 7.4.3 U.K.
  • 7.4.4 Italy
  • 7.4.5 Russia
  • 7.4.6 Nordic
  • 7.4.7 Rest of Europe

8 China

• 8.1 China Prostate Cancer Testing Market Size (2015-2026)
• 8.2 China Prostate Cancer Testing Market Size by Type (2015-2020)
• 8.3 China Prostate Cancer Testing Market Size by Application (2015-2020)
• 8.4 China Prostate Cancer Testing Market Size by Region (2015-2020)
  • 8.4.1 China
  • 8.4.2 Japan
  • 8.4.3 South Korea
  • 8.4.4 Southeast Asia
  • 8.4.5 India
  • 8.4.6 Australia
  • 8.4.7 Rest of Asia-Pacific

9 Japan

• 9.1 Japan Prostate Cancer Testing Market Size (2015-2026)
• 9.2 Japan Prostate Cancer Testing Market Size by Type (2015-2020)
• 9.3 Japan Prostate Cancer Testing Market Size by Application (2015-2020)
• 9.4 Japan Prostate Cancer Testing Market Size by Country (2015-2020)
  • 9.4.1 Mexico
  • 9.4.2 Brazil

10 Southeast Asia

• 10.1 Southeast Asia Prostate Cancer Testing Market Size (2015-2026)
• 10.2 Southeast Asia Prostate Cancer Testing Market Size by Type (2015-2020)
• 10.3 Southeast Asia Prostate Cancer Testing Market Size by Application (2015-2020)
• 10.4 Southeast Asia Prostate Cancer Testing Market Size by Country (2015-2020)
  • 10.4.1 Turkey
  • 10.4.2 Saudi Arabia
  • 10.4.3 UAE
  • 10.4.4 Rest of Middle East & Africa

11 Key Players Profiles

• 11.1 Genomic Health
  • 11.1.1 Genomic Health Company Details
  • 11.1.2 Genomic Health Business Overview
  • 11.1.3 Genomic Health Prostate Cancer Testing Introduction
  • 11.1.4 Genomic Health Revenue in Prostate Cancer Testing Business (2015-2020))
  • 11.1.5 Genomic Health Recent Development
• 11.2 OPKO
  • 11.2.1 OPKO Company Details
  • 11.2.2 OPKO Business Overview
  • 11.2.3 OPKO Prostate Cancer Testing Introduction
  • 11.2.4 OPKO Revenue in Prostate Cancer Testing Business (2015-2020)
  • 11.2.5 OPKO Recent Development
• 11.3 Siemens Healthcare
  • 11.3.1 Siemens Healthcare Company Details
  • 11.3.2 Siemens Healthcare Business Overview
  • 11.3.3 Siemens Healthcare Prostate Cancer Testing Introduction
  • 11.3.4 Siemens Healthcare Revenue in Prostate Cancer Testing Business (2015-2020)
  • 11.3.5 Siemens Healthcare Recent Development
• 11.4 DiaSorin
  • 11.4.1 DiaSorin Company Details
  • 11.4.2 DiaSorin Business Overview
  • 11.4.3 DiaSorin Prostate Cancer Testing Introduction
  • 11.4.4 DiaSorin Revenue in Prostate Cancer Testing Business (2015-2020)
  • 11.4.5 DiaSorin Recent Development
• 11.5 bioMeriux
  • 11.5.1 bioMeriux Company Details
  • 11.5.2 bioMeriux Business Overview
  • 11.5.3 bioMeriux Prostate Cancer Testing Introduction
  • 11.5.4 bioMeriux Revenue in Prostate Cancer Testing Business (2015-2020)
  • 11.5.5 bioMeriux Recent Development
• 11.6 Roche
  • 11.6.1 Roche Company Details
  • 11.6.2 Roche Business Overview
  • 11.6.3 Roche Prostate Cancer Testing Introduction
  • 11.6.4 Roche Revenue in Prostate Cancer Testing Business (2015-2020)
  • 11.6.5 Roche Recent Development
• 11.7 MDx Health
  • 11.7.1 MDx Health Company Details
  • 11.7.2 MDx Health Business Overview
  • 11.7.3 MDx Health Prostate Cancer Testing Introduction
  • 11.7.4 MDx Health Revenue in Prostate Cancer Testing Business (2015-2020)
  • 11.7.5 MDx Health Recent Development
• 11.8 Beckman Coulter
  • 11.8.1 Beckman Coulter Company Details
  • 11.8.2 Beckman Coulter Business Overview
  • 11.8.3 Beckman Coulter Prostate Cancer Testing Introduction
  • 11.8.4 Beckman Coulter Revenue in Prostate Cancer Testing Business (2015-2020)
  • 11.8.5 Beckman Coulter Recent Development
• 11.9 Myriad Genetics
  • 11.9.1 Myriad Genetics Company Details
  • 11.9.2 Myriad Genetics Business Overview
  • 11.9.3 Myriad Genetics Prostate Cancer Testing Introduction
  • 11.9.4 Myriad Genetics Revenue in Prostate Cancer Testing Business (2015-2020)
  • 11.9.5 Myriad Genetics Recent Development
• 11.10 Ambry Genetics
  • 11.10.1 Ambry Genetics Company Details
  • 11.10.2 Ambry Genetics Business Overview
  • 11.10.3 Ambry Genetics Prostate Cancer Testing Introduction
  • 11.10.4 Ambry Genetics Revenue in Prostate Cancer Testing Business (2015-2020)
  • 11.10.5 Ambry Genetics Recent Development

12 Analyst's Viewpoints/Conclusions

13 Appendix

• 13.1 Research Methodology
  • 13.1.1 Methodology/Research Approach
  • 13.1.2 Data Source
• 13.2 Disclaimer